AMRI Selected to Support AstraZeneca in Delivery of COVID-19 Vaccine
COVID-19: Updates from AMRI
Request a quote for:
- Analytical Services
- in vitro DMPK Services
- Aseptic Fill Finish Services
- Antimicrobial discovery testing services
Submit Samples For Analytical Testing
Learn more about the sample studies we perform and reports we provide.
Navigate the Journey From Pipeline to Portfolio With a Trusted Partner.See our solutions
The Latest from AMRI
September 3, 2020
AMRI’s Albuquerque Facility Is Set to Provide Sterile Fill/Finish Manufacture of AstraZeneca’s AZD1222 Vaccine Candidate Through 2021 ALBANY, N.Y.–(BUSINESS...
August 13, 2020
La Jolla, California–(Newsfile Corp. – August 13, 2020) – Tryp Therapeutics Inc. (“Tryp” or the “Company”), a clinical-stage pharmaceutical company...
July 8, 2020
July 08, 2020 10:30 AM Eastern Daylight Time WESTPORT, Conn.–(BUSINESS WIRE)–ViralClear Pharmaceuticals, Inc. (ViralClear), supported by Albany Molecular Research Inc., (AMRI), a...
June 11, 2020
DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx Inc. today announced it has entered into two agreements with Neurotrope, Inc. (Nasdaq: NTRP) to acquire Neurotrope’s...